Chicago Partners Investment Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $635K | Buy |
3,732
+161
| +5% | +$27.4K | 0.02% | 507 |
|
|
2025
Q1 | $575K | Sell |
3,571
-1,654
| -32% | -$266K | 0.02% | 482 |
|
|
2024
Q4 | $702K | Sell |
5,225
-850
| -14% | -$114K | 0.02% | 421 |
|
|
2024
Q3 | $776K | Sell |
6,075
-151
| -2% | -$19.3K | 0.03% | 382 |
|
|
2024
Q2 | $834K | Sell |
6,226
-433
| -7% | -$58K | 0.03% | 358 |
|
|
2024
Q1 | $964K | Sell |
6,659
-227
| -3% | -$32.9K | 0.04% | 322 |
|
|
2023
Q4 | $924K | Sell |
6,886
-1,964
| -22% | -$263K | 0.04% | 314 |
|
|
2023
Q3 | $771K | Buy |
8,850
+1,562
| +21% | +$136K | 0.04% | 320 |
|
|
2023
Q2 | $665K | Sell |
7,288
-389
| -5% | -$35.5K | 0.03% | 355 |
|
|
2023
Q1 | $612K | Buy |
7,677
+5
| +0.1% | +$399 | 0.04% | 340 |
|
|
2022
Q4 | $893K | Sell |
7,672
-2,287
| -23% | -$266K | 0.05% | 280 |
|
|
2022
Q3 | $1.24M | Buy |
9,959
+2,093
| +27% | +$261K | 0.09% | 207 |
|
|
2022
Q2 | $673K | Buy |
7,866
+85
| +1% | +$7.27K | 0.05% | 287 |
|
|
2022
Q1 | $669K | Sell |
7,781
-1,465
| -16% | -$126K | 0.05% | 260 |
|
|
2021
Q4 | $1.13M | Buy |
9,246
+185
| +2% | +$22.5K | 0.08% | 204 |
|
|
2021
Q3 | $1.4M | Sell |
9,061
-212
| -2% | -$32.8K | 0.1% | 176 |
|
|
2021
Q2 | $1.05M | Sell |
9,273
-1,868
| -17% | -$211K | 0.08% | 204 |
|
|
2021
Q1 | $1.51M | Buy |
11,141
+3,302
| +42% | +$448K | 0.12% | 143 |
|
|
2020
Q4 | $1.26M | Buy |
7,839
+4,537
| +137% | +$729K | 0.12% | 146 |
|
|
2020
Q3 | $550K | Buy |
+3,302
| New | +$550K | 0.07% | 217 |
|